We firmly believe that there is an even more seamless, efficient and personalised way to meet customer needs in the Swiss healthcare sector. That's why we have joined forces to form Switzerland’s largest healthcare network.
Annual report 2022: Galenica is still growing strongly.
With an increase in sales of 4.7% to CHF 4,014.3 million and an adjusted EBIT of CHF 200.8 million (-5.8%), Galenica achieved very good results.
Hundreds of new jobs are waiting for you.
The Galenica network is growing.
We offer a wide range of careers for dedicated talented individuals from all disciplines and at all levels of experience.
Find the right job for you now:
|Aktueller Kurs (@TODO: translate)||74.25 CHF|
|absolute change||+0.15 CHF|
23.03.2023 - 17:30:27
Annual results of the Galenica Group 2022
Galenica achieves strong results in 2022 and increases dividend again
Galenica Group’s Media and Analyst Conference
Galenica has hosted its Media and Analyst Conference on 7 March 2023.
Verfora continues to expand its complementary medicine portfolio
The Galenica subsidiary Verfora will acquire 100% of Padma Ltd. at the end of January.
The Galenica network.
«Our success depends on how well we can anticipate the major changes in our society and in the healthcare system and offer adequate solutions. For our customers, for our partners, for our employees and thus also for society in our country!»
Marc Werner, CEO